closeup-mri-brain-blood-vessels-person-with-severe-headaches.jpg

Brain Health

Strengthening Payment and Care Supports for Brain Health

Improving Early-Stage Alzheimer’s Disease Care

Nearly seven million Americans are living with Alzheimer’s disease, a number expected to double by 2060. Yet Alzheimer’s care remains fragmented, with diagnosis often delayed and both medical and non-medical interventions out of reach for many. The recent availability of early-stage disease modifying treatments, targeted medical and lifestyle management, and the development of diagnostic biomarkers can shift this landscape — supporting a health system better equipped to deliver Alzheimer’s treatment that maintains quality of life over the long-term.

By The Numbers

13.8 million

number of Americans expected to be living with Alzheimer’s disease in 2060 ¹

75%

estimated percentage of undiagnosed dementia cases globally ²

average per-person Medicare payments for dementias compared to beneficiaries without these conditions ¹

$360 billion

share of Americans who face barriers accessing specialty care ¹

40%

approximate share of specialty clinicians participating in value-based care payment models ³

1: 2024 Alzheimer's disease facts and figures

2: Undiagnosed dementia cases

3: Dementia, nursing staff, and health outcomes in nursing homes

shot-of-a-mature-woman-being-comforted-by-a-doctor-2025-04-06-07-29-39-utc.jpg

Reimaging Alzheimer’s Care for an Aging Nation

Accelerator initiatives aim to fundamentally reimagine the way we diagnose, treat, and pay for Alzheimer’s disease care — shifting our system from reactive and fragmented care to proactive and coordinated care. We will take a data-driven and sustainable approach that prioritizes:

Identifying the major barriers to early diagnosis and care, and the opportunities to overcome them.

Strengthening early intervention and management by developing best practices gained from expert stakeholder engagement — from clinicians and payers to policymakers and patients.

Building a preliminary care and payment model for early-stage Alzheimer’s disease that is patient- and caregiver-centric and reduces the burden on primary care providers.